Health
Egypt's drug authority meets Sandoz on localizing oncology medicines
Coverage
2 reports · over 2 hours
Egypt's drug regulator met Sandoz's Egypt and Libya leadership on Sunday to discuss localizing oncology medicines and speeding registration of high-quality generics.
- Meeting: Ali El-Ghamrawy, head of the Egyptian Drug Authority, met Dragos Toma, Sandoz's director for Egypt and Libya, to review the company's oncology localization plans.
- Sandoz: Toma said the company is committed to localizing oncology preparations in the Egyptian market and expanding the availability of its medicines there.
- Regulator: El-Ghamrawy said the authority will provide the regulatory support needed to speed access to high-quality drugs and expand local manufacturing.
- South Africa: The meeting reviewed Sandoz's participation in a joint Egyptian-South African pilot for assessing regulatory files.

